|
TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
POTENTIATION OF ANTIHYPERTENSIVE DRUGS
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
BETABLOCKERS MAY EXACERBATE REBOUND HYPERTENSION FOLLOWING CLONIDINE WITHDRAWAL, SO IF CLONIDINE IS TO BE WITHDRAWN THEN BETABLOCKERS SHOULD BE DISCONTINUED SEVERAL DAYS BEFORE CLONIDINE
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CLONIDINE CO-ADMINISTRATION WITH AGENTS KNOWN TO AFFECT SINUS NODE FUNCTION OR A.V. NODAL CONDUCTION LIKE DIGOXIN,CALCIUM CHANNEL BLOCKER & BETABLOCKER MAY CAUSE BRADYCARDIA & A.V. BLOCK
|
CO-ADMINISTRATION MAY POTENTIATE HYPERTENSIVE EFFECT OF THE DRUG
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
OESTROGENS REDUCE EFFECTS OF ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|